• Media
  • Subscribe
  • Contact
  • IPO
    • ENG
    • SWE
Cinclus Pharma Cinclus Pharma
  • ENG
  • SWE
  • About us
    • About us

      Company History

      Company strategy

      Career

      Licensed partners

      Board of directors

      Management team

    • Company History
    • Company strategy
    • Career
    • Licensed partners
    • Board of directors
    • Management team
  • Our science
    • Our science

      About GERD

      Patient story – Life with GERD

      Patient Story - Everyday life with GERD

      Linaprazan glurate

      PPIs versus PCABs

      Development strategy

      Clinical development

    • About GERD
    • Linaprazan glurate
    • Development strategy
    • Clinical development
  • Governance
    • Governance

      Corporate Governance Reports

      General Meetings

      2025

      2024

      2023

      2022

      Board of directors

      The work of the board

      Board committees

      Management

      Founders & Senior Advisors

      Nomination Committee

      Nomination committee instructions

      Remuneration

      Guidelines for remuneration

      Remuneration reports

      Auditing

      Articles of Association

      Internal control

    • Corporate Governance Reports
    • General Meetings
    • Board of directors
    • Management
    • Founders & Senior Advisors
    • Nomination Committee
    • Remuneration
    • Auditing
    • Articles of Association
    • Internal control
  • Investors
    • Investors

      The Share

      Ownership structure

      Dividend policy

      Analyst coverage

      Redeye’s research of Cinclus Pharma

      Financial Reports

      Press releases

      Calendar

      Presentations

    • The Share
    • Financial Reports
    • Press releases
    • Calendar
    • Presentations
  • Media
  • Subscribe
  • Contact
  • IPO
  • Home /
  • Investors /
  • Financial Reports
  • Investors
    • The Share
      • Ownership structure
      • Dividend policy
      • Analyst coverage
      • Redeye’s research of Cinclus Pharma
    • Financial Reports
    • Press releases
    • Calendar
    • Presentations
Investors

Financial Reports

Find information about Cinclus Pharma's latest reports and presentations here.

Presentations

Invitation to presentation of Cinclus Pharma’s third quarter report 2025

Invitation to presentation of Cinclus Pharma’s third quarter report 2025

20 Nov 2025 10:00

Webinar

Cinclus Pharma’s third quarter report for July–September 2025 will be published on Thursday, November 20, 2025, at 08:00 am CET. The company will host…

See all

 

Cinclus Pharma

Cinclus Pharma Holding AB (publ)

Postal address:
Cinclus Pharma
Kungsbron 1
111 22 Stockholm
SWEDEN

Visiting address:
Cinclus Pharma
Kungsbron 1
Elevator G, Level 4
111 22 Stockholm
SWEDEN

Phone: +46 8-133310
E-mail: info@cincluspharma.com

Navigate

  • About us
  • Our science

Join our network


© CINCLUS PHARMA 2025Privacy policy